Pay in 4 interest-free payments of $7.49 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Regulatory & Legal Status AOD-9604 has no FDA-approved therapeutic use and has never been cleared for human consumption by any government health authority worldwide it exists in a pre-clinical/discontinued-development status, which is the basis for its banned classification
As a general rule: Safe usage window: Up to 28 days after the first puncture Label the vial: Write the opening date on the label Refrigeration: Not required but storing in a cool, dry place is recommended Need help with preparation
The key is not returning to full load simply because the pain has resolved, because BPC-157s anti-inflammatory effect precedes the structural repair
Gastrointestinal effects dominate the side effect profile
Mood Evidence has linked depression with B-12 deficiency
US$ 24.17
US$ 28.69
US$ 22.08
